Finally, where use of a patient's own cells is not possible, either because a sufficient number of cells cannot be obtained or because protocols for generating the required cell type in the lab (e.g., from induced pluripotent stem cells) have not yet been developed, the consequences of immunosupprtession must also be considered. Banking human embryonic stem cell and induced pluripotent stem cell lines is one way to ensure that patients can receive cells with a good immunological match, thus minimizing any required immunosuppression (Turner et al., 2013)
No comments:
Post a Comment